In humans, HspA5 is upregulated in prefrontal cortex neurons of ALS patients, and its increased cytoplasmic expression appears to mitigate TDP-43-induced toxicity in Drosophila, identifying HspA5 as a potential target in TDP43-associated diseases [69]. This evidence concerns the gene TARDBP and amyotrophic lateral sclerosis.